SHALLCROSS STEVEN A bought TOVX
January 5, 2026 · Form 4 insider transaction
SHALLCROSS STEVEN A bought 475,000 shares of Theriva Biologics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
475,000
Price
$0.00
Total value
N/A
InsiderSHALLCROSS STEVEN A
Role—
SecurityStock Options (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after475,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These stock options vest pro rata on a monthly basis over 36 months.